Split-luciferase complementation to measure soluble epoxide hydrolase dimerization
OHSU # 1803
- Jonathan Nelson, SM-Anesthesiology, MMG
- Nabil Alkayed, SM.Anesthesiology & Perioperative Medicine
- Xiangshu Xiao, SM.Physiology and Pharmacology
Novel assay and technique to monitor the effect of mutations on dimerization. The enzyme soluble epoxide hydrolase (sEH) forms a catalytically active dimer with predominantly cytosolic localization. Disrupting dimerization, on the other hand, reduces sEH hydrolase activity and shifts the sub-cellular localization of sEH to peroxisomes. The peroxisomal localization of sEH may contribute to the protective role in a number of different diseases such as ischemia. To identify small molecular inhibitors of sEH dimerization, a novel assay was developed using a split-firefly luciferase strategy.
For more information, contact:
Senior Technology Development Manager